1. Home/
  2. Compounds/
  3. doxorubicin:navitoclax (2:1 mol/mol)

doxorubicin:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2doxorubicin:navitoclax (2:1 mol/mol)
PharmacoGx doxorubicin:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to doxorubicin:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA TIGD3 CTRPv2 pan-cancer AAC 0.2 4e-09
mRNA ARHGAP19-SLIT1 CTRPv2 pan-cancer AAC 0.23 4e-09
mRNA MUM1 CTRPv2 pan-cancer AAC 0.2 4e-09
mRNA MARCKSL1 CTRPv2 pan-cancer AAC 0.19 4e-09
mRNA CTC1 CTRPv2 pan-cancer AAC 0.22 4e-09
mRNA ARHGAP19 CTRPv2 pan-cancer AAC 0.24 5e-09
mRNA NUP133 CTRPv2 pan-cancer AAC 0.2 5e-09
mRNA CIC CTRPv2 pan-cancer AAC 0.2 5e-09
mRNA ABHD17B CTRPv2 pan-cancer AAC 0.2 5e-09
mRNA GMEB1 CTRPv2 pan-cancer AAC 0.21 5e-09
Download CSV